EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
   2.4.1.62 | -999 |
- |
- |
489314 |
| 2.4.1.62 | -999 |
- |
relative activity: GalNAcalpha: 1.4%, GalNAcbeta: 1.9%, GM2: 38%, lyso-GM2: 0.3%, GA2: 100% |
692522 |
| 2.4.1.62 | -999 |
- |
relative activity: GalNAcalpha: 3.0%, GalNAcbeta: 50.5%, GM2: 100%, lyso-GM2: 606%, GA2: 8.8% |
692522 |
| 2.4.1.62 | -999 |
- |
relative activity: GalNAcalpha: 6.4%, GalNAcbeta: 47.5%, GM2: 100%, lyso-GM2: 444%, GA2: 29% |
692522 |
| 2.4.1.62 | -999 |
- |
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 158 (substrate: GalNAcalpha), 192 (substrate: GalNAcbeta), 210 (substrate: GM2), 83.5 (substrate: IFNalpha2b) |
692522 |
| 2.4.1.62 | -999 |
- |
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 9.7 (substrate: GalNAcalpha), 4.8 (substrate: GalNAcbeta), 4.5 (substrate: GM2), 86.9 (substrate: GA2) |
692522 |
| 2.4.1.62 | -999 |
- |
specific activity of N-term MalE–CgtBOH4384 fusion construct (mU/mg): 13.6 (substrate: GalNAcalpha), 40.4 (substrate: GalNAcbeta), 27 (substrate: GM2) |
692522 |
| 2.4.1.62 | 0.00000005 |
- |
recombinant enzyme, crude cell homogenate of transfected NIH 3T3 cells |
489315 |
| 2.4.1.62 | 0.000000051 |
- |
recombinant enzyme, crude cell homogenate of transfected CHO-K1 cells |
489316 |
| 2.4.1.62 | 0.00000007 |
- |
recombinant enzyme, crude cell homogenate of transfected CHO-K1 cells |
489315 |
